Skip to main content
Premium Trial:

Request an Annual Quote

It Just Kinda Does

"Given the huge numbers of possible compounds, and the relatively tiny fraction of those we can screen, why does high-throughput screening even work at all?" asks Derek Lowe at In the Pipeline. A recent paper from the Shoichet group at UCSF compared the contents of different screening libraries to what natural products generally look like, finding that the libraries appear to lean toward having compounds with structures similar to natural products, which, Lowe says, "we can reasonably assume have generally evolved to have some sort of biological activity."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.